Notably, of the three enzymes that use Kyn as a substrate, KAT and kynureninase are unsaturated enzymes that are able to utilize the increased availability of Kyn resulting from KMO deficiency (e.g., in the brains of individuals with schizophrenia) [50]. The gene discussed is KYNU; the disease is schizophrenia.